Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

China flag China · Delayed Price · Currency is CNY
25.55
+0.06 (0.24%)
Sep 30, 2025, 3:00 PM CST
0.24%
Market Cap39.58B
Revenue (ttm)75.78B
Net Income (ttm)2.80B
Shares Out1.63B
EPS (ttm)1.72
PE Ratio14.82
Forward PE13.84
Dividend0.80 (3.13%)
Ex-Dividend DateSep 12, 2025
Volume8,593,182
Average Volume12,037,955
Open25.47
Previous Close25.49
Day's Range25.35 - 25.57
52-Week Range24.56 - 33.72
Beta0.26
RSI36.71
Earnings DateOct 27, 2025

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; and rese... [Read more]

Sector Healthcare
Founded 1997
Employees 28,048
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600332
Full Company Profile

Financial Performance

In 2024, SHA:600332's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial Statements

News

There is no news available yet.